STOCK TITAN

Ceapro Stock Price, News & Analysis

CRPOF OTC
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.47%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.27%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.21%
Tags
none
Rhea-AI Summary

Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) announced the appointment of Michel Regnier as Senior Vice President, Technical Operations, effective May 1, 2023. With over 20 years of experience in operations and engineering across the medical device, pharmaceutical, and aerospace industries, Regnier will oversee Ceapro's bioprocessing business unit and the implementation of a pilot scale unit for Pressurized Gas eXpanded (PGX) Technology at the Agri Food Discovery Place in Edmonton.

Regnier aims to enhance product development and support the company's strategic growth as it focuses on commercialization and partnerships for its disruptive technologies. Ceapro continues to strengthen its leadership team and propel its evolution in the biopharmaceutical field.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management

FAQ

What is the current stock price of Ceapro (CRPOF)?

The current stock price of Ceapro (CRPOF) is $0.17 as of February 7, 2025.